Koubaissi Salwa A, Kamar Zeinab, El Ankouni Mahdi, Degheili Jad A, Haddad Antoine
Department of Internal Medicine, American University of Beirut-Medical Center, Beirut, Lebanon.
Department of Anaesthesiology, Lebanese University, Beirut, Lebanon.
Heart Views. 2020 Oct-Dec;21(4):239-244. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_87_20. Epub 2021 Jan 14.
Coronary artery disease (CAD) is a major cause of death and disability worldwide. Coronary computed tomographic angiography (CCTA) is a noninvasive imaging technique with a high negative predictive value (NPV). Most studies were done in developed countries, where the prevalence of CAD does not reflect the actual disease burden in developing countries, such as Lebanon.
We retrospectively evaluated the prognostic value of CCTA in predicting acute myocardial events (AMEs) in 200 Lebanese patients. We determined if specific medical and radiological characteristics are linked with AME and looked for any association between the patient's medical risk factors and the type/location of detected atheromatous plaques. Patients' records were reviewed, and the follow-up period of 5-8 years ensued. Chi-square/Fisher test and Student's -test were used, in addition to multinomial logistic regression to adjust for the confounding variables. <0.05 was considered statistically significant.
Our study showed that CCTA had a NPV that reaches 97.9% in asymptomatic patients, a positive predictive value (PPV) of 76.4% for symptomatic patients, a sensitivity of 88.9%, and a specificity of 52.5%. AMEs were significantly increased in patients with a mixed plaque type and/or a moderate-to-severe lumen reduction on CCTA.
CCTA is a sensitive modality for plaque detection and is found to have a remarkably high NPV for asymptomatic patients. A CCTA, along with a low pretest clinical probability of CAD, can be sufficient to rule out an AME for up to 8 years.
冠状动脉疾病(CAD)是全球死亡和残疾的主要原因。冠状动脉计算机断层血管造影(CCTA)是一种具有高阴性预测值(NPV)的非侵入性成像技术。大多数研究是在发达国家进行的,而这些国家CAD的患病率并不能反映黎巴嫩等发展中国家的实际疾病负担。
我们回顾性评估了CCTA对200例黎巴嫩患者急性心肌事件(AME)的预测价值。我们确定了特定的医学和放射学特征是否与AME相关,并寻找患者的医学风险因素与检测到的动脉粥样硬化斑块的类型/位置之间的任何关联。对患者的记录进行了审查,并进行了5至8年的随访。除了使用多项逻辑回归来调整混杂变量外,还使用了卡方检验/费舍尔检验和学生t检验。P<0.05被认为具有统计学意义。
我们的研究表明,CCTA在无症状患者中的NPV达到97.9%,在有症状患者中的阳性预测值(PPV)为76.4%,敏感性为88.9%,特异性为52.5%。在CCTA上显示为混合斑块类型和/或中度至重度管腔狭窄的患者中,AME显著增加。
CCTA是一种检测斑块的敏感方法,并且发现对无症状患者具有非常高的NPV。CCTA结合较低的CAD预测试临床概率,足以在长达8年的时间内排除AME。